Health.com: What is a cytokine storm?
UC expert explains how some COVID-19 patients' immune systems turn deadly
Health.com interviewed Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases for a story on the impact cytokine storms have on the immune systems of COVID-19 patients.
Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases. Photo/Joe Fuqua III/UC Creative + Brand
One of the most mystifying aspects of the pandemic is why some patients have no symptoms while others get so sick they need to be put on a ventilator.
Fichtenbaum says part of the body's response to an infection involves releasing cytokines, biological chemicals that stimulate cell pathways and allow for communication between cells.
"Normally, cytokines are meant to be helpful to us in moderation," explains Dr. Fichtenbaum, "but when a certain pathway is engaged [too much] the immune system starts causing damage to the patient."
Read the full article here.
Featured image at top of a cytokine storm/Getty Images
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
Telescope captures information about lonely Jupiter-like gas giant
May 13, 2026
Science outlets highlight a University of Cincinnati student's collaborative discoveries about an exoplanet 901 light years away.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.